Trial Details

COMPLETED
Basic Information
Clinical ID c163
Identifier NCT04045782
Trial Title Evaluation of the Safety and Effectiveness of Switching From Humira to Imraldi in Flanders
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: single arm
Participant Information
Sponsor Pieter Dewint, MD PhD
City Aalst
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2019-08-19
Primary Completion Date 2021-01-29
Completion Date 2021-01-29